Skip to main content
. 2023 May 2;66(3):E246–E263. doi: 10.1503/cjs.005922

Table 5.

Evidence-based assessment of hormonal therapy in patients with inherited bleeding disorders68

Hormonal product Efficacy Other clinical factors
Levonorgestrel-releasing intrauterine system Most effective therapy for heavy menstrual bleeding
  • Provides 5 yr of therapy

  • Contraception failure rate < 0.1%

  • Removal requested by patient in 17%–20% of cases

  • Spontaneous expulsion rate 8% (decreased with associated use of tranexamic acid)

Combined hormonal contraception (birth control pill, transdermal patch and vaginal ring) Effective for contraception and menses suppression
  • Can be used monthly or continuously for 12 mo

  • Break-through bleeding can occur

Progesterone only (pill, intramuscular medroxyprogesterone or intradermal implant) Reduces menstrual blood loss with irregular bleeding